Digital Short-term crucial to future of AI drug discovery One of the lead prospects in a new generation of AI-developed drug candidates struggled in late-stage trials.
Digital The benefits of adopting a truly digital mindset for pharmac... Historically, the pharmaceutical industry has been in the laggard phase when it comes to digital adoption.
Digital The precision element at the heart of digital transformation On the final day of Reuters Pharma Barcelona back in March, web editor Nicole Raleigh sat down with Graphite Digital’s CEO, Rob Verheul.
Digital AI in drug development: A reality check In this episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what the potential of AI in drug discovery
Digital Relevance and impact: Connecting with HCPs in the digital ag... What’s the best way to influence physician behaviour? This is the pharmaceutical industry’s billion-dollar question.
Digital Combatting longstanding challenges in rare disease detection... Approximately 350 million people are living with up to 8,000 rare diseases worldwide.
News Kennedy changes vaccine panel charter after legal setback A change to the ACIP charter has raised concerns of even greater political influence over the vaccine panel by HHS Secretary Kennedy.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
